Dora Pascual-Salcedo Selected Research

Dora Pascual-Salcedo Research Topics

Disease

42	Rheumatoid Arthritis 01/2024 - 04/2004
4	Necrosis 01/2024 - 12/2012
4	Rheumatic Diseases (Rheumatism) 01/2024 - 10/2015
4	Atherosclerosis 01/2016 - 05/2012
4	Inflammation (Inflammations) 02/2013 - 08/2005
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2020 - 03/2010
3	Arthritis (Polyarthritis) 12/2019 - 05/2007
3	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2018 - 06/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 07/2014 - 12/2011
2	Axial Spondyloarthritis 01/2019 - 01/2018
2	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 01/2007
2	Thrombosis (Thrombus) 01/2018 - 06/2013
2	Stroke (Strokes) 01/2015 - 01/2013
2	Genetic Predisposition to Disease (Genetic Predisposition) 05/2007 - 12/2006
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2006 - 01/2005
1	Multiple Sclerosis 01/2021
1	Progressive Multifocal Leukoencephalopathy 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Overweight 01/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2017
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 09/2016
1	Ankylosing Spondylitis 07/2013
1	Venous Thrombosis (Deep-Vein Thrombosis) 06/2013
1	Melanoma (Melanoma, Malignant) 08/2012
1	Dyslipidemias (Dyslipidemia) 08/2012
1	Neoplasms (Cancer) 08/2012
1	Cytomegalovirus Infections (Inclusion Disease) 09/2006

Drug/Important Bio-Agent (IBA)

13	Tumor Necrosis Factor InhibitorsIBA 01/2024 - 07/2013
12	Infliximab (Remicade)FDA Link 01/2024 - 04/2004
12	AntibodiesIBA 01/2024 - 05/2007
5	Adalimumab (Humira)FDA Link 01/2020 - 03/2015
5	Proteins (Proteins, Gene)FDA Link 12/2019 - 01/2010
5	Biomarkers (Surrogate Marker)IBA 01/2019 - 05/2012
4	Anti-Citrullinated Protein AntibodiesIBA 12/2019 - 05/2010
4	HLA-DRB1 Chains (HLA DRB1)IBA 01/2019 - 01/2010
4	Immunoglobulin G (IgG)IBA 01/2018 - 06/2013
3	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 03/2019
3	Immunoglobulin M (IgM)IBA 01/2018 - 06/2013
3	golimumab FDA Link 01/2018 - 12/2014
3	Etanercept (Enbrel)FDA Link 11/2017 - 01/2014
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 03/2014
2	Rheumatoid FactorIBA 01/2024 - 01/2010
2	AutoantibodiesIBA 12/2019 - 01/2019
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 11/2019 - 02/2013
2	Antirheumatic Agents (DMARD)IBA 03/2019 - 01/2019
2	C-Reactive ProteinIBA 01/2016 - 02/2013
2	Antiphospholipid AntibodiesIBA 01/2015 - 06/2013
2	Interleukin-6 (Interleukin 6)IBA 01/2014 - 12/2011
2	Interleukin-15 (Interleukin 15)IBA 05/2007 - 04/2006
2	CytokinesIBA 05/2007 - 04/2006
1	B-Cell Activating FactorIBA 09/2022
1	Natalizumab (Tysabri)FDA Link 01/2021
1	CT-P13IBA 10/2020
1	Biosimilar PharmaceuticalsIBA 10/2020
1	Rituximab (Mabthera)FDA Link 01/2020
1	Anti-Idiotypic AntibodiesIBA 01/2019
1	Immunoglobulin A (IgA)IBA 01/2018
1	Interferon Regulatory FactorsIBA 07/2014
1	Genetic Markers (Genetic Marker)IBA 01/2014
1	OsteoprotegerinIBA 01/2014
1	Carrier Proteins (Binding Protein)IBA 06/2013
1	Phospholipids (Phosphatides)FDA LinkGeneric 06/2013
1	Prothrombin (Factor II)IBA 06/2013
1	Glycoproteins (Glycoprotein)IBA 06/2013
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 02/2013
1	cyclic citrullinated peptideIBA 01/2013
1	Monoclonal AntibodiesIBA 12/2012
1	CollagenIBA 08/2012
1	Interleukin-23 (Interleukin 23)IBA 01/2012
1	EpitopesIBA 01/2012
1	Acid PhosphataseIBA 07/2011
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 03/2010
1	Complement Factor H (Factor H)IBA 08/2009
1	Chemokine CCL26IBA 08/2009
1	MHC class II transactivator proteinIBA 08/2009
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 08/2009
1	Interleukin-2 (IL2)IBA 01/2009
1	interleukin-21 (interleukin 21)IBA 01/2009
1	Peptides (Polypeptides)IBA 05/2007
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2007
1	Tyrosine (L-Tyrosine)FDA Link 01/2007
1	3' Untranslated Regions (3' UTR)IBA 12/2006
1	Messenger RNA (mRNA)IBA 12/2006
1	Indicators and Reagents (Reagents)IBA 09/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2005
1	Interleukin-12 Receptors (Interleukin 12 Receptor)IBA 06/2005
1	Interleukin-12 (IL 12)IBA 06/2005
1	OsteopontinIBA 03/2005
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2005

Therapy/Procedure

10	Therapeutics 01/2021 - 04/2004
1	Duration of Therapy 01/2021
1	Biological Therapy 01/2021